In pathological conditions like macrophage activation syndrome (MAS), COVID-19 and inflammatory bowel diseases (IBD), IL-18 is upregulated and plays an important role in the disease development (1, 5, 8–13). This evidence concerns the gene IL18 and COVID-19.